Abstract
The prognosis of oesophageal cancer is poor (10–15% 5-year survival rate) and dysphagia is a common complication in advancing disease. Palliative therapy aims to relieve dysphagia and prevent fistulation. Brachytherapy (intraluminal radiotherapy) and stenting are two commonly used palliative techniques for relieving dysphagia. The relative effectiveness of these techniques is not known. The role of teletherapy (TT) supplementary to intraluminal high dose rate (ILHDR) brachytherapy (BT) in the palliation of advanced oesophageal cancer (E33021). Available from: http://www-crp.iaea.org/ (Searched Jan 2005). A randomized phase III study in advanced oesophageal cancer to compare palliation of dysphagia in patients treated with radiotherapy versus chemo-radiotherapy (TROG 03.01/ NCIC CTG ES2). Available from: http://www.ranzcr.edu.au, http://www.ctg.queensu.ca/ (Searched Jan 2005).
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
